In a new analysis of 52 studies, researchers found that people with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and gout may have a higher stroke risk than that of the general population.
Most rheumatologists and public health experts urge people with axial spondyloarthritis (which includes ankylosing spondylitis) to get the vaccine as soon as possible.
Higher pain sensitivity in either ankylosing spondylitis or non-radiographic axial spondyloarthritis is associated with having worse disease and health outcomes, which shows there’s an unmet need for better pain management for all axial spondyloarthritis patients.
Once you realize you may have this inflammatory arthritis, telling a rheumatologist about all of your symptoms will help you get a diagnosis and access to effective treatments.
Non-radiographic axial spondyloarthritis (nr-axSpA) is not exactly a household name, which can lead to delays in diagnosis and treatment for this often-debilitating back pain. Being aware of inflammatory back pain and other symptoms may help you get to a faster diagnosis and better quality of life.
“There are loads of people who fall into this new disease category who will be able get the treatment they need because of the wider diagnostic net it casts,” says non-radiographic axial spondyloarthritis patient Ricky White.
“Even if you’re not a medical professional who knows how to narrow down a differential diagnosis, you’re still the best expert on what your body is experiencing,” says non-radiographic axial spondyloarthritis patient Sarah Islam.
Fibromyalgia is common in people with axial spondyloarthritis (axSpA), but it’s also not a permanent condition. Here’s what researchers found about the connection between fibro and axSpA.
Significantly more men than women saw an improvement in their disease activity a year after starting a biologic, but more research is needed to understand why.
The American College of Rheumatology’s 2020 medical conference had a number of important updates that people living with axial spondyloarthritis (or their caregivers) should know about, from the role of “treat to target” to gender differences in symptoms.